Clinical trials - Press Releases

Date	Title	Company
22-Mar-2023	Greenphire Launches Patient-Powered Research Registry Allowing Foundations to Better Engage and Support Patients	Greenphire
22-Mar-2023	ABPI response to MHRA clinical trials framework	ABPI
22-Mar-2023	Vaccitech’s VTP-200 Ph 1b/2 Study Demonstrates Favorable Tolerability and Immunogenicity Profile at Interim Analysis in Women with Low-Grade Human Papillomavirus (HPV)-related Cervical Lesions	Vaccitech
22-Mar-2023	iO:M8 receives CE-IVD certification	PreciPoint GmbH
21-Mar-2023	MHRA to streamline clinical trial approvals in biggest overhaul of trial regulation in 20 years	MHRA
17-Mar-2023	Phase 3 Study Shows XTANDI® (enzalutamide) plus Leuprolide Significantly Improves Metastasis-Free Survival in Men with Nonmetastatic Prostate Cancer	Astellas Pharma Ltd
17-Mar-2023	TrakCel and Lonza complete integration milestone to combine cell and gene therapy manufacturing and orchestration solutions	TrakCel
16-Mar-2023	OKYO Pharma Announces Phase 2 Trial of OK-101 Drug to Treat Dry Eye Disease is now listed on the ClinicalTrials.gov Public Website	OKYO Pharma
16-Mar-2023	Clinion Launches Revolutionary AI-Powered Medical Coding Solution for Clinical Trials	clinion
15-Mar-2023	Immutep announces initiation of phase II/III trial for eftilagimod alpha plus paclitaxel in metastatic breast cancer	Immutep
15-Mar-2023	Mural Health and ProofPilot Partner to Streamline Payments and Provide More Patient Choice	Discovery PR
13-Mar-2023	Greenphire Expands Agreement with Merck to Help Reduce Financial and Travel Barriers for Clinical Trial Participants Worldwide	Greenphire
13-Mar-2023	Calliditas Announces Primary Endpoint Successfully Met in Phase 3 NefIgArd Trial Evaluating Nefecon® in IgA Nephropathy	Calliditas
13-Mar-2023	New drug to lower brain pressure could treat blinding IIH headaches, trial finds	University of Birmingham
09-Mar-2023	Antev Receives US FDA Guidance on Teverelix® Phase 3 Trial Design for Treating Advanced Prostate Cancer Patients with Increased Cardiovascular Risk	Antev Ltd
08-Mar-2023	UK clinical trial for potential new endometriosis treatment, funded by Wellbeing of Women and the Scottish Government, offers hope to millions of women	Wellbeing of Women
07-Mar-2023	Dupixent® (dupilumab) application for treatment of chronic spontaneous urticaria (CSU) in adults and adolescents accepted for FDA review	Sanofi
07-Mar-2023	AB2 Bio Completes Enrolment in Pivotal Phase 3 Trial of Tadekinig alfa to Treat Primary Monogenic IL-18 Driven HLH	AB2 Bio
07-Mar-2023	Increasing female representation in science	Broughton Group
07-Mar-2023	Participants Dosed on Adessia® in Germany in a Phase 1 Trial, a First for an Adalimumab Biosimilar Candidate Developed in Africa	MiGenTra